Self calibrating blood chamber

US9308306B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9308306-B2
Application numberUS-201414188193-A
CountryUS
Kind codeB2
Filing dateFeb 24, 2014
Priority dateFeb 24, 2014
Publication dateApr 12, 2016
Grant dateApr 12, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An optical blood monitoring system and corresponding method avoid the need to obtain a precise intensity value of the light impinging upon the measured blood layer during the analysis. The system is operated to determine at least two optical measurements through blood layers of different thickness but otherwise substantially identical systems. Due to the equivalence of the systems, the two measurements can be compared so that the bulk extinction coefficient of the blood can be calculated based only on the known blood layer thicknesses and the two measurements. Reliable measurements of various blood parameters can thereby be determined without certain calibration steps.

First claim

Opening claim text (preview).

The invention claimed is: 1. A blood chamber for use in a hemodialysis system operable to monitor at least one blood constituent, the blood chamber comprising a body defining an internal volume for receiving blood to be monitored by the hemodialysis system, the body including: a first wall, disposed on a light inlet side of the body, configured to pass light from a light source into the internal volume; a second wall, disposed on a light outlet side of the body, configured to pass the light from the light source out of the internal volume towards light sensors; an inlet for supplying blood to the internal volume; and an outlet for withdrawing blood from the internal volume; wherein the blood chamber provides a first optical path extending through the body for the light from the light source, the first optical path orthogonally traversing a region of the first wall, passing through a section of the internal volume that has a first thickness extending from the first wall to the second wall, and orthogonally traversing a section of the second wall; wherein the blood chamber further provides a second optical path extending through the body for the light from the light source, the second optical path orthogonally traversing another region of the first wall, passing through a section of the internal volume that has a second thickness extending from the first wall to the second wall, and orthogonally traversing another region of the second wall, wherein the second thickness is substantially greater than the first thickness and the first and second optical paths are disposed at an angle; wherein the region of the first wall that is traversed by the first optical path is disposed at a non-zero angle γ to the region of the first wall that is traversed by the second optical path, and wherein the region of the second wall that is traversed by the first optical path is disposed at the non-zero angle γ to the region of the second wall that is traversed by the second optical path; and wherein the first and second optical paths are disposed on either side of an axis through the light source and pass through the internal volume where blood flows through the blood chamber. 2. The blood chamber recited in claim 1 , wherein the region of the first wall that is traversed by the first optical path has an equal thickness to the region of the first wall that is traversed by the second optical path. 3. The blood chamber recited in claim 1 , wherein the region of the second wall that is traversed by the first optical path has an equal thickness to the region of the second wall that is traversed by the second optical path.

Assignees

Inventors

Classifications

  • specially adapted to extracorporeal circuits · CPC title

  • used specific wavelengths · CPC title

  • hematocrit · CPC title

  • Flow-through cuvettes (G01N21/09 takes precedence; handling fluid samples G01N1/10) · CPC title

  • Transmissivity (G01N21/25 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9308306B2 cover?
An optical blood monitoring system and corresponding method avoid the need to obtain a precise intensity value of the light impinging upon the measured blood layer during the analysis. The system is operated to determine at least two optical measurements through blood layers of different thickness but otherwise substantially identical systems. Due to the equivalence of the systems, the two meas…
Who is the assignee on this patent?
Fresenius Med Care Hldg Inc
What technology area does this patent fall under?
Primary CPC classification A61M1/3609. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).